v3.21.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
General and administrative $ 1,704 $ 391
Research and development 3,482 218
Acquired in-process research and development 0 2,126
Total operating expenses 5,186 2,735
Loss from operations (5,186) (2,735)
Interest expense 0 (554)
Fair value change in warrant liabilities and premium conversion derivatives (33,829) 198
Other income 1 3
Loss before income taxes (39,014) (3,088)
Benefit (provision) for income taxes 0 0
Net loss (39,014) (3,088)
Other comprehensive loss, net of tax 0 0
Comprehensive loss $ (39,014) $ (3,088)
Net loss per share:    
Basic (Note 10) (in dollars per shares) $ (3.57) $ (0.87)
Diluted (Note 10) (in dollars per shares) $ (3.57) $ (0.87)
Number of shares used in per share calculations:    
Basic (in shares) 10,923,651 3,547,990
Diluted (in shares) 10,923,651 3,547,990

Source